These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14556867)

  • 1. Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after coronary arterial stenting.
    Aggarwal A; Schneider DJ; Sobel BE; Dauerman HL
    Am J Cardiol; 2003 Oct; 92(8):924-9. PubMed ID: 14556867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD40 ligand is an early initiator of inflammation after coronary intervention.
    Aggarwal A; Blum A; Schneider DJ; Sobel BE; Dauerman HL
    Coron Artery Dis; 2004 Dec; 15(8):471-5. PubMed ID: 15585987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
    Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
    Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response.
    Aggarwal A; Schneider DJ; Terrien EF; Gilbert KE; Dauerman HL
    J Thromb Thrombolysis; 2003 Feb; 15(1):25-31. PubMed ID: 14574073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Am J Cardiol; 2002 Feb; 89(4):372-6. PubMed ID: 11835913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis.
    Caixeta AM; Brito FS; Costa MA; Serrano CV; Petriz JL; Da Luz PL
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):500-7. PubMed ID: 17285569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques.
    Aggarwal A; Schneider DJ; Terrien EF; Sobel BE; Dauerman HL
    Am J Cardiol; 2004 Jan; 93(1):6-9. PubMed ID: 14697457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory response to coronary stent implantation in patients with unstable angina.
    Sánchez-Margalet V; Cubero JM; Martín-Romero C; Cubero J; Cruz-Fernández JM; Goberna R
    Clin Chem Lab Med; 2002 Aug; 40(8):769-74. PubMed ID: 12392302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous coronary intervention.
    Gogo PB; Schneider DJ; Terrien EF; Watkins MW; Sobel BE; Dauerman HL
    Am J Cardiol; 2005 Aug; 96(4):538-42. PubMed ID: 16098308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early release of neutrophil markers of activation after direct stenting in patients with unstable angina.
    Gach O; Biémar C; Nys M; Deby-Dupont G; Chapelle JP; Deby C; Lamy M; Piérard LA; Legrand V
    Coron Artery Dis; 2005 Feb; 16(1):59-65. PubMed ID: 15654202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the inflammatory response between patients with and those without diabetes mellitus after coronary stenting.
    Paiva MS; Serrano CV; Nicolau JC; Jalbut BO; Fernandes JL; De Lemos JA; Blotta MH; De Oliveira RT; De Oliveira IR; De Oliveira Lda A; Ramires JA
    J Interv Cardiol; 2008 Oct; 21(5):403-9. PubMed ID: 18705636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN; Chalikias GK; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Atherosclerosis; 2007 Jul; 193(1):196-203. PubMed ID: 16857204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    Dibra A; Mehilli J; Braun S; Hadamitzky M; Baum H; Dirschinger J; Schühlen H; Schömig A; Kastrati A
    Am Heart J; 2005 Aug; 150(2):344-50. PubMed ID: 16086941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting.
    Doo YC; Han SJ; Han SW; Park WJ; Choi SH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rim CY; Lee KH; Lee Y
    Clin Cardiol; 2005 Feb; 28(2):72-6. PubMed ID: 15757077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.
    Liuzzo G; Buffon A; Biasucci LM; Gallimore JR; Caligiuri G; Vitelli A; Altamura S; Ciliberto G; Rebuzzi AG; Crea F; Pepys MB; Maseri A
    Circulation; 1998 Dec; 98(22):2370-6. PubMed ID: 9832480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.
    Park DW; Lee CW; Yun SC; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Heart; 2007 Sep; 93(9):1087-92. PubMed ID: 17309906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
    Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
    Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.